J. David Gladstone Institutes
| Award Total: $8,094,180 | # of Grants: 21 |
Investigators
ThomasInnerarityPh.D. - RobertPitasPh.D. - BeatrizLevy-WilsonPh.D. - MartinHersbergerPh.D. - Murielle MarieVeniantPh.D. - RobertPitasPh.D. - DavidDichekM.D. - ThomasInnerarityPh.D. - StephenYoungM.D. - RobertPitasPh.D. - IsraelCharoM.D., Ph.D. - MartinBergoM.D., Ph.D. - JohanBjorkegrenM.D., Ph.D. - YadongHuangM.D., Ph.D. - StephenYoungM.D. - RobertPitasPh.D. - RobertPitasPh.D. - RobertRaffaiPh.D. - MartinBergoM.D., Ph.D. - UgurHodoglugilM.D., Ph.D. - KimberlyCordesPh.D. - NathalieGaboritPh.D. - SwetansuHotaPh.D - ManonEckhardtPh.D. -
Grants
| A Differential Approach to Investigate Head and Neck Cancer | 2016 (Cycle 25) | $118,800 |
| Early Diagnosis/Pathogenesis | Postdoctoral Fellowship Awards | |
| Chromatin remodellers Brg1 and Baf60c in heart development | 2013 (Cycle 22) | $145,800 |
| Early Diagnosis/Pathogenesis | Postdoctoral Fellowship Awards | |
| Triglyceride metabolism: Genetics, smoking and heart disease | 2003 (Cycle 12) | $75,438 |
| Cardiovascular Disease | Postdoctoral Fellowship Awards | |
| Enzymatic targets for anticancer therapy | 2002 (Cycle 11) | $267,304 |
| Cancer | New Investigator Awards | |
| Remnant lipoproteins, apolipoprotein E4 and atherosclerosis | 2001 (Cycle 10) | $400,500 |
| Cardiovascular Disease | New Investigator Awards | |
| ApoE isoforms, fatty acid metabolism and atherosclerosis | 2001 (Cycle 10) | $691,616 |
| Cardiovascular Disease | Research Project Awards | |
| Post-isoprenylation processing steps as anticancer targets | 2000 (Cycle 9) | $1,017,450 |
| Cancer | Research Project Awards | |
| Apolipoprotein E: remnant metabolism and atherogenesis | 1999 (Cycle 8) | $793,474 |
| Cardiovascular Disease | Research Project Awards | |
| A model system for smoking-related damage to proteins | 1999 (Cycle 8) | $75,375 |
| Cardiovascular Disease | Postdoctoral Fellowship Awards | |
| Importance of Rce1 and Ras in tobacco-induced cancers | 1999 (Cycle 8) | $75,209 |
| Cancer | Postdoctoral Fellowship Awards | |
| Monocyte Chemoattractant Protein (MCP-1) in Atherosclerosis | 1994 (Cycle 3) | $484,207 |
| Cardiovascular Disease | Research Project Awards | |
| Role of the Acetyl LDL Receptor in Atherogenesis | 1994 (Cycle 3) | $121,187 |
| Cardiovascular Disease | Research Project Awards | |
| Lipoprotein classes and susceptibility to atherosclerosis | 1998 (Cycle 7) | $702,940 |
| Cardiovascular Disease | Research Project Awards | |
| Determining how cholesterol-rich Lp(a) causes heart disease | 1998 (Cycle 7) | $797,092 |
| Cardiovascular Disease | Research Project Awards | |
| Towards gene therapy for tobacco-related vascular disease | 1998 (Cycle 7) | $719,328 |
| Cardiovascular Disease | Research Project Awards | |
| Will apoE cause regression of atherosclerotic lesions? | 1998 (Cycle 7) | $165,299 |
| Cardiovascular Disease | Research Project Awards | |
| How does cardiac fuel metabolism influence heart disease? | 1998 (Cycle 7) | $262,005 |
| Cardiovascular Disease | New Investigator Awards | |
| How are beneficial cholesterol transport proteins produced? | 1998 (Cycle 7) | $37,069 |
| Cardiovascular Disease | Postdoctoral Fellowship Awards | |
| Expression of the Human apo-B Gene in Transgenic Mice | 1995 (Cycle 4) | $211,090 |
| Cardiovascular Disease | Research Project Awards | |
| Proteins that Remove Atherogeneic Lipoproteins from Blood | 1995 (Cycle 4) | $678,254 |
| Cardiovascular Disease | Research Project Awards | |
| Cloning & Expression of the Apo-B mRNA Editing Factor | 1994 (Cycle 3) | $254,743 |
| Cardiovascular Disease | Research Project Awards | |